Eculizumab for treatment of asthma

Author： Smith Steven G   Watson Brittany   Clark Gordon   Gauvreau Gail M  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.12, Iss.4, 2012-04, pp. : 529-537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma

By Ghazi Aasia   Trikha Anita   Calhoun William J  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 113-118

Informa Healthcare

Access to resources Recommend Favorite

Pitrakinra for asthma

By Antoniu Sabina A   Cojocaru Ileana  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1609-1615

Informa Healthcare

Access to resources Recommend Favorite

Oxidative and nitrosative events in asthma

By Andreadis A.A.   Hazen S.L.   Comhair S.A.A.   Erzurum S.C.  

Free Radical Biology and Medicine, Vol. 35, Iss. 3, 2003-08 ,pp. : 213-225

Elsevier

Access to resources Recommend Favorite

Targeting of eosinophils in asthma

By Molfino Nestor A  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 807-809

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab for pediatric asthma

By Townley Robert G   Agrawal Swati   Sapkota Kiran  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1595-1608

Informa Healthcare

Access to resources Recommend Favorite